Table 2.
Performance of algorithm after application to 1209 clinical P. aeruginosa isolates from a US surveillance study.
| Algorithm-Derived Screening Criteria | Number Meeting Criteria | Carbapenemase Producers Detected | Carbapenemase Producers Missed by Criteria |
|---|---|---|---|
| IPM + MEM- Resistant AND FEP + CAZ + TZP- Non-Susceptible |
116 | 7/116 | 0 |
| IPM + MEM- Resistant AND FEP + CAZ + TZP- Non-Susceptible + CZA- Resistant |
43 | 7/43 | 0 |
| IPM + MEM- Resistant AND FEP + CAZ + TZP- Non-Susceptible + C/T- Resistant |
21 | 6/21 | 1 * |
| IPM + MEM- Resistant AND FEP + CAZ + TZP- Non-Susceptible + C/T- Resistant + CZA-Resistant |
19 | 6/19 | 1 * |
IPM = imipenem; MEM = meropenem; FEP = cefepime; CAZ = ceftazidime; TZP = piperacillin/tazobactam; CZA = ceftazidime/avibactam; C/T = ceftolozane/tazobactam. * Genotype: blaOXA-2, blaOXA-50, and PAO.